Determination of anxiety, depression, avoidance and obsessions experienced by hemodialysis patients during the COVID-19.

IF 1.5 4区医学 Q3 HEMATOLOGY

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-06-29 DOI:10.1111/1744-9987.14031

Nazlı Koşunalp, Mehtap Kavurmaci

{"title":"Determination of anxiety, depression, avoidance and obsessions experienced by hemodialysis patients during the COVID-19.","authors":"Nazlı Koşunalp, Mehtap Kavurmaci","doi":"10.1111/1744-9987.14031","DOIUrl":null,"url":null,"abstract":"Introduction: The purpose of this study was to ascertain the levels of anxiety, despair, avoidance, and obsessions that hemodialysis patients dealt with during the pandemic.Methods: The study was conducted with 139 hemodialysis patients. Research data \"Coronavirus Anxiety Scale (CAS),\" \"Hospital Anxiety and Depression Scale (HAD),\" \"COVID-19 Avoidance Scale\" (AA-COVID-19) and \"Coronavirus Obsession Scale (OCS).\" The data obtained from the research were analyzed using the SPSS 21 package program.Results: The average score of the patients on the CAS scale was 0.73 ± 1.17, on the HAD-A scale was 5.94 ± 3.67, and on the HAD-D scale was 7.06 ± 3.89. The COVID-19 outbreak has consequently had a severe impact on hemodialysis patients' mental health.Conclusion: Covid 19 epidemic, the health sector failed to protect the mental health of patients. However, new epidemics and disasters await the world in the future. In these results show that new strategies need to be developed.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1070-1078"},"PeriodicalIF":1.5000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Apheresis and Dialysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1744-9987.14031","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The purpose of this study was to ascertain the levels of anxiety, despair, avoidance, and obsessions that hemodialysis patients dealt with during the pandemic.

Methods: The study was conducted with 139 hemodialysis patients. Research data "Coronavirus Anxiety Scale (CAS)," "Hospital Anxiety and Depression Scale (HAD)," "COVID-19 Avoidance Scale" (AA-COVID-19) and "Coronavirus Obsession Scale (OCS)." The data obtained from the research were analyzed using the SPSS 21 package program.

Results: The average score of the patients on the CAS scale was 0.73 ± 1.17, on the HAD-A scale was 5.94 ± 3.67, and on the HAD-D scale was 7.06 ± 3.89. The COVID-19 outbreak has consequently had a severe impact on hemodialysis patients' mental health.

Conclusion: Covid 19 epidemic, the health sector failed to protect the mental health of patients. However, new epidemics and disasters await the world in the future. In these results show that new strategies need to be developed.

查看原文本刊更多论文

新冠肺炎期间血液透析患者经历的焦虑、抑郁、回避和强迫的测定。

引言：本研究的目的是确定血液透析患者在疫情期间的焦虑、绝望、回避和痴迷程度。方法：对139例血液透析患者进行研究。研究数据“冠状病毒焦虑量表（CAS）”、“医院焦虑和抑郁量表（HAD）”、《新冠肺炎回避量表》（AA-CVID-19）和《冠状病毒困扰量表（OCS）》。结果：患者在CAS量表上的平均得分为0.73 ± 1.17，HAD-A评分为5.94 ± 3.67，HAD-D量表为7.06 ± 3.89.新冠肺炎疫情因此对血液透析患者的心理健康产生了严重影响。结论：新冠肺炎疫情19日，卫生部门未能保护患者的心理健康。然而，新的流行病和灾难在未来等待着世界。这些结果表明，需要制定新的战略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic Apheresis and Dialysis 医学-泌尿学与肾脏学

CiteScore

3.00

自引率

10.50%

发文量

166

审稿时长

6-12 weeks

期刊介绍： Therapeutic Apheresis and Dialysis is the official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis and the Japanese Society for Dialysis Therapy. The Journal publishes original articles, editorial comments, review articles, case reports, meeting abstracts and Communications information on apheresis and dialysis technologies and treatments.